Search Results - "Welles HC"

Impaired systemic antibody response against gut microbiota pathobionts in critical illness and susceptibility to nosocomial infections.

Authors: Cho, Nicole A. Schlechte, Jared Yu, Ian-ling et al.

Source: Intensive Care Medicine Experimental. 1/27/2026, Vol. 14 Issue 1, p1-17. 17p.

Exploring the Impact of Airway Microbiome on Asthma Morbidity: A Focus on the "Constructing a 'Eubiosis Reinstatement Therapy' for Asthma—CURE" Project.

Authors: Xepapadaki, Paraskevi Megremis, Spyridon Rovina, Nikoletta et al.

Source: Pulmonary Therapy. Jun2024, Vol. 10 Issue 2, p171-182. 12p.

SIV Env RhmAbs + N-803 at ART initiation prolongs viral decay without disrupting reservoir establishment in SIV-infected infant macaques.

Authors: Farinre, Omotayo Anaya, Tzoalli King, Alexis C. et al.

Source: PLoS Pathogens. 1/10/2025, Vol. 21 Issue 1, p1-21. 21p.

Pharmacokinetics, pharmacodynamics, and toxicity of a PD-1-targeted IL-15 in cynomolgus monkeys.

Authors: Ji, Changhua Kuang, Bing Buetow, Bernard S. et al.

Source: PLoS ONE. 2/5/2024, Vol. 19 Issue 2, p1-21. 21p.

A phase 1 study of interleukin-15 in combination with avelumab in relapsed or refractory T-cell lymphoma.

Authors: Gordon, Max J. Dubois, Sigrid Bryant, Bonita et al.

Source: Leukemia & Lymphoma. Jul2024, Vol. 65 Issue 7, p1008-1011. 4p.

Context-specific roles for IL-17 in tuberculosis.

Authors: Maseeme, Mahlatse Tezera, Liku B. Noursadeghi, Mahdad et al.

Source: PLoS Pathogens. 4/21/2026, Vol. 22 Issue 4, p1-18. 18p.

IL-15: from discovery to FDA approval.

Authors: Li, Zihai Wrangle, John He, Kai et al.

Source: Journal of Hematology & Oncology. 2/18/2025, Vol. 18 Issue 1, p1-5. 5p.

Potent broadly neutralizing antibodies mediate efficient antibody-dependent phagocytosis of HIV-infected cells.

Authors: Snow, Brian J. Keles, Nida K. Grunst, Michael W. et al.

Source: PLoS Pathogens. 10/28/2024, Vol. 20 Issue 10, p1-21. 21p.

Potent antibody-dependent cellular cytotoxicity of a V2-specific antibody is not sufficient for protection of macaques against SIV challenge.

Authors: Grunst, Michael W. Gil, Hwi Min Grandea III, Andres G. et al.

Source: PLoS Pathogens. 1/22/2024, Vol. 20 Issue 1, p1-21. 21p.

Total and regional fat-to-muscle mass ratio and risks of pan-cancer: a prospective cohort study.

Authors: Wang, Ruizhi Xu, Yudi Zhang, Yuyuan et al.

Source: BMC Medicine. 5/30/2025, Vol. 23 Issue 1, p1-16. 16p.

Translocating bacteria in SIV infection are not stochastic and preferentially express cytosine methyltransferases.

Authors: Flynn JK Ortiz AM Vujkovic-Cvijin I et al.

Source: Mucosal immunology [Mucosal Immunol] 2024 Oct; Vol. 17 (5), pp. 1089-1101. Date of Electronic Publication: 2024 Jul 31.

Publication Type: Journal Article

Journal Info: Publisher: Elsevier Country of Publication: United States NLM ID: 101299742 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1935-3456 (Electronic) Linking ISSN: 19330219 NLM ISO Abbreviation: Mucosal Immunol Subsets: MEDLINE

Predictive value of temporal muscle thickness for prognosis in newly diagnosed IDH wild-type glioblastoma patients: evaluated for a Chinese population.

Authors: Zha, Boya Ma, Yajing Zha, Boqun et al.

Source: European Radiology. Aug2025, Vol. 35 Issue 8, p4438-4447. 10p.

Subjects: Prognosis, Overall survival, Progression-free survival, Glioblastoma multiforme, Chinese people, Muscle mass

Geographic Terms: China

Broad coverage of neutralization-resistant SIV strains by second-generation SIV-specific antibodies targeting the region involved in binding CD4.

Authors: Welles HC King HAD Nettey L et al.

Source: PLoS pathogens [PLoS Pathog] 2022 Jun 16; Vol. 18 (6), pp. e1010574. Date of Electronic Publication: 2022 Jun 16 (Print Publication: 2022).

Publication Type: Journal Article; Research Support, N.I.H., Extramural; Research Support, N.I.H., Intramural

Journal Info: Publisher: Public Library of Science Country of Publication: United States NLM ID: 101238921 Publication Model: eCollection Cited Medium: Internet ISSN: 1553-7374 (Electronic) Linking ISSN: 15537366 NLM ISO Abbreviation: PLoS Pathog Subsets: MEDLINE

Viral vector delivered immunogen focuses HIV-1 antibody specificity and increases durability of the circulating antibody recall response.

Authors: Williams, LaTonya D. Shen, Xiaoying Sawant, Sheetal S. et al.

Source: PLoS Pathogens. 5/31/2023, Vol. 18 Issue 5, p1-46. 46p.

Oxidation and reduction analysis of therapeutic recombinant human interleukin-15 by HPLC and LC-MS.

Authors: Wang, Yang Chen, Huanhuan Zhao, Meiqi et al.

Source: Applied Microbiology & Biotechnology; May2023, Vol. 107 Issue 10, p3217-3227, 11p

Advances in Immune-Based Approaches for the Cure of HIV Infection.

Authors: Wagner JA Sandel DA Deitchman AN et al.

Source: Drugs [Drugs] 2026 Jun; Vol. 86 (6), pp. 851-870. Date of Electronic Publication: 2026 May 02.

Publication Type: Journal Article; Review

Journal Info: Publisher: Adis, Springer International Country of Publication: New Zealand NLM ID: 7600076 Publication Model: Print-Electronic Cited Medium: Internet ISSN: 1179-1950 (Electronic) Linking ISSN: 00126667 NLM ISO Abbreviation: Drugs Subsets: MEDLINE

Antibody-dependent cellular cytotoxicity, infected cell binding and neutralization by antibodies to the SIV envelope glycoprotein.

Authors: Grunst, Michael W. Ladd, Ruby A. Clark, Natasha M. et al.

Source: PLoS Pathogens. 5/30/2023, Vol. 18 Issue 5, p1-26. 26p.

Neoadjuvant immunochemotherapy plus thymalfasin in locally advanced gastric cancer: a prospective clinical trial.

Authors: Xu H Li F Li B et al.

Source: BMC medicine [BMC Med] 2026 Feb 26; Vol. 24 (1). Date of Electronic Publication: 2026 Feb 26.

Publication Type: Journal Article; Clinical Trial, Phase II

Journal Info: Publisher: BioMed Central Country of Publication: England NLM ID: 101190723 Publication Model: Electronic Cited Medium: Internet ISSN: 1741-7015 (Electronic) Linking ISSN: 17417015 NLM ISO Abbreviation: BMC Med Subsets: MEDLINE

Use of 3D-CT-derived psoas major muscle volume in defining sarcopenia in colorectal cancer.

Authors: Takahashi, Makoto Sakamoto, Kazuhiro Kogure, Yosuke et al.

Source: BMC Cancer. 6/18/2024, Vol. 24 Issue 1, p1-10. 10p.

Combining TIGIT blockade with IL‐15 stimulation is a promising immunotherapy strategy for lung adenocarcinoma.

Authors: Luo, Baohong Sun, Yu Zhan, Qinru et al.

Source: Clinical & Translational Medicine. Jan2024, Vol. 14 Issue 1, p1-20. 20p.